Skip to main content

Obesity Topic Center

Industry Insights

news


News
07/24/2026
Grace Taylor, MS, MA
A large US cohort study found that only 3% of adults newly diagnosed with obesity underwent metabolic bariatric surgery within one year, with provider type, body mass index, sex, and other clinical factors strongly influencing access to...
A large US cohort study found that only 3% of adults newly diagnosed with obesity underwent metabolic bariatric surgery within one year, with provider type, body mass index, sex, and other clinical factors strongly influencing access to...
A large US cohort study found...
07/24/2026
First Report Managed Care
News
07/21/2026
Hannah Musick
Researchers identified an obesity subphenotype characterized by rapid gastric emptying and low endogenous GLP-1 production that achieved nearly twice the weight loss with tirzepatide as other obesity phenotypes, highlighting the potential for...
Researchers identified an obesity subphenotype characterized by rapid gastric emptying and low endogenous GLP-1 production that achieved nearly twice the weight loss with tirzepatide as other obesity phenotypes, highlighting the potential for...
Researchers identified an...
07/21/2026
First Report Managed Care
News
04/17/2026
Rebecca Amrick
A large observational study of a US administrative claims database examined the effects of semaglutide on health care resource utilization (HCRU) and medical costs in patients with overweight or obesity (OW/OB) and multimorbidity.
A large observational study of a US administrative claims database examined the effects of semaglutide on health care resource utilization (HCRU) and medical costs in patients with overweight or obesity (OW/OB) and multimorbidity.
A large observational study of a...
04/17/2026
First Report Managed Care
News
03/13/2026
Lisa Kuhns, PhD, MD
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests semaglutide not only drives meaningful weight loss but may also improve muscle strength and reduce sarcopenic obesity in patients with severe obesity.
A real-world study suggests...
03/13/2026
First Report Managed Care
News
03/05/2026
Grace Taylor, MS, MA
New National Health and Nutrition Examination Survey (NHANES) data show that more than 40% of U.S. adults have obesity, with severe obesity continuing to rise and persistent disparities across age, sex, and racial groups.
New National Health and Nutrition Examination Survey (NHANES) data show that more than 40% of U.S. adults have obesity, with severe obesity continuing to rise and persistent disparities across age, sex, and racial groups.
New National Health and...
03/05/2026
First Report Managed Care
News
02/13/2026
Juliet Gallagher
A newly developed patient-reported outcome (PRO) instrument—the Weight and Emotions Scale (WES)—demonstrated strong content validity in US adults with obesity or overweight. Developed in alignment with US Food and Drug Administration guidance...
A newly developed patient-reported outcome (PRO) instrument—the Weight and Emotions Scale (WES)—demonstrated strong content validity in US adults with obesity or overweight. Developed in alignment with US Food and Drug Administration guidance...
A newly developed...
02/13/2026
First Report Managed Care
News
02/10/2026
Grace Taylor, MS, MA
A revised obesity framework that goes beyond body mass index (BMI) alone captures a significantly larger share of US adults with elevated risk for metabolic disease, cardiovascular events, and mortality.
A revised obesity framework that goes beyond body mass index (BMI) alone captures a significantly larger share of US adults with elevated risk for metabolic disease, cardiovascular events, and mortality.
A revised obesity framework that...
02/10/2026
First Report Managed Care
News
11/04/2025
Grace Taylor, MS, MA
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek by the Veterans Health Administration found that patients with type 2 diabetes taking GLP-1 receptor agonists showed significantly lower rates of unhealthy alcohol use, suggesting potential behavioral benefits...
A study presented at ObesityWeek...
11/04/2025
First Report Managed Care
News
10/21/2024
Lisa Kuhns, PhD, MD
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the...
10/21/2024
First Report Managed Care
News
10/08/2024
Jolynn Tumolo
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection...
10/08/2024
First Report Managed Care